# Treatment of Zollinger-Ellison Syndrome With Prevacid

> **NCT00204373** · PHASE4 · COMPLETED · sponsor: **Charles Mel Wilcox, MD** · enrollment: 72 (actual)

## Conditions studied

- Zollinger-Ellison Syndrome
- Multiple Endocrine Neoplasia

## Interventions

- **DRUG:** Lansoprazole (Prevacid)

## Key facts

- **NCT ID:** NCT00204373
- **Lead sponsor:** Charles Mel Wilcox, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2012-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00204373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00204373, "Treatment of Zollinger-Ellison Syndrome With Prevacid". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00204373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*